Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s10072-023-06683-2.pdf
Reference48 articles.
1. Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211
2. Park JW, Moon HS, Kim JM, Lee KS, Chu MK (2014) Chronic daily headache in Korea: prevalence, clinical characteristics, medical consultation and management. J Clin Neurol 10(3):236–243. https://doi.org/10.3988/jcn.2014.10.3.236
3. GBDH Collaborators (2018) Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17(11):954–976. https://doi.org/10.1016/S1474-4422(18)30322-3
4. Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37(4):631–649. https://doi.org/10.1016/j.ncl.2019.06.001
5. Bigal ME, Lipton RB (2011) Migraine chronification. Curr Neurol Neurosci Rep 11(2):139–148. https://doi.org/10.1007/s11910-010-0175-6
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Are we closer to achieving precision medicine for migraine treatment? A narrative review;Cephalalgia;2024-09
2. Revolutionizing migraine management: advances and challenges in CGRP-targeted therapies and their clinical implications;Frontiers in Neurology;2024-06-13
3. Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine;Frontiers in Neurology;2024-06-03
4. Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world;Journal of Neurology, Neurosurgery & Psychiatry;2024-05-22
5. Medication “underuse” headache;Cephalalgia;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3